Genflow Biosciences plc (LON:GENF – Get Free Report)’s share price shot up 2.4% during mid-day trading on Monday . The stock traded as high as GBX 2.20 and last traded at GBX 2.14. 832,539 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 2,331,012 shares. The stock had previously closed at GBX 2.09.
Genflow Biosciences Stock Performance
The business’s fifty day simple moving average is GBX 2.25 and its 200-day simple moving average is GBX 2.03. The company has a market capitalization of £12.34 million, a P/E ratio of -6.56 and a beta of 2.31.
Genflow Biosciences (LON:GENF – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported GBX (0.33) earnings per share for the quarter. Genflow Biosciences had a return on equity of 377.33% and a net margin of 840.76%.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Read More
- Five stocks we like better than Genflow Biosciences
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
